Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30


Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies.

Grallert H, Dupuis J, Bis JC, Dehghan A, Barbalic M, Baumert J, Lu C, Smith NL, Uitterlinden AG, Roberts R, Khuseyinova N, Schnabel RB, Rice KM, Rivadeneira F, Hoogeveen RC, Fontes JD, Meisinger C, Keaney JF Jr, Lemaitre R, Aulchenko YS, Vasan RS, Ellis S, Hazen SL, van Duijn CM, Nelson JJ, März W, Schunkert H, McPherson RM, Stirnadel-Farrant HA, Psaty BM, Gieger C, Siscovick D, Hofman A, Illig T, Cushman M, Yamamoto JF, Rotter JI, Larson MG, Stewart AF, Boerwinkle E, Witteman JC, Tracy RP, Koenig W, Benjamin EJ, Ballantyne CM.

Eur Heart J. 2012 Jan;33(2):238-51. doi: 10.1093/eurheartj/ehr372. Epub 2011 Oct 14.


Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators.

Schnabel RB, Baumert J, Barbalic M, Dupuis J, Ellinor PT, Durda P, Dehghan A, Bis JC, Illig T, Morrison AC, Jenny NS, Keaney JF Jr, Gieger C, Tilley C, Yamamoto JF, Khuseyinova N, Heiss G, Doyle M, Blankenberg S, Herder C, Walston JD, Zhu Y, Vasan RS, Klopp N, Boerwinkle E, Larson MG, Psaty BM, Peters A, Ballantyne CM, Witteman JC, Hoogeveen RC, Benjamin EJ, Koenig W, Tracy RP.

Blood. 2010 Jul 1;115(26):5289-99. doi: 10.1182/blood-2009-05-221382. Epub 2009 Dec 29.


Genetic variation in Fc gamma receptor IIa and risk of coronary heart disease: negative results from two large independent populations.

Karakas M, Hoffmann MM, Vollmert C, Rothenbacher D, Meisinger C, Winkelmann B, Khuseyinova N, Böhm BO, Illig T, März W, Koenig W.

BMC Med Genet. 2009 May 29;10:46. doi: 10.1186/1471-2350-10-46.


Determinants of the acute-phase protein C-reactive protein in myocardial infarction survivors: the role of comorbidities and environmental factors.

Rückerl R, Peters A, Khuseyinova N, Andreani M, Koenig W, Meisinger C, Dimakopoulou K, Sunyer J, Lanki T, Nyberg F, Schneider A.

Clin Chem. 2009 Feb;55(2):322-35. doi: 10.1373/clinchem.2008.112334. Epub 2008 Dec 18.


Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence.

Koenig W, Khuseyinova N.

Cardiovasc Drugs Ther. 2009 Feb;23(1):85-92. doi: 10.1007/s10557-008-6135-6. Epub 2008 Oct 24. Review.


Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

Holzapfel C, Baumert J, Grallert H, Müller AM, Thorand B, Khuseyinova N, Herder C, Meisinger C, Hauner H, Wichmann HE, Koenig W, Illig T, Klopp N.

Eur J Endocrinol. 2008 Oct;159(4):407-16. doi: 10.1530/EJE-08-0356. Epub 2008 Jul 1.


RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

Herder C, Illig T, Baumert J, Müller M, Klopp N, Khuseyinova N, Meisinger C, Poschen U, Martin S, Koenig W, Thorand B.

Eur J Endocrinol. 2008 May;158(5):R1-5. doi: 10.1530/EJE-07-0686.


Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol.

Kolz M, Baumert J, Müller M, Khuseyinova N, Klopp N, Thorand B, Meisinger C, Herder C, Koenig W, Illig T.

BMC Med Genet. 2008 Feb 25;9:9. doi: 10.1186/1471-2350-9-9.


Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

Herder C, Illig T, Baumert J, Müller M, Klopp N, Khuseyinova N, Meisinger C, Martin S, Thorand B, Koenig W.

Atherosclerosis. 2008 Oct;200(2):380-8. doi: 10.1016/j.atherosclerosis.2007.12.025. Epub 2008 Feb 1.


Variability of serial lipoprotein-associated phospholipase A2 measurements in post myocardial infarction patients: results from the AIRGENE Study Center Augsburg.

Khuseyinova N, Greven S, Rückerl R, Trischler G, Loewel H, Peters A, Koenig W.

Clin Chem. 2008 Jan;54(1):124-30. Epub 2007 Nov 16.


DNA variants, plasma levels and variability of C-reactive protein in myocardial infarction survivors: results from the AIRGENE study.

Kolz M, Koenig W, Müller M, Andreani M, Greven S, Illig T, Khuseyinova N, Panagiotakos D, Pershagen G, Salomaa V, Sunyer J, Peters A; AIRGENE Study Group.

Eur Heart J. 2008 May;29(10):1250-8. Epub 2007 Oct 22.


Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.

Herder C, Klopp N, Baumert J, Müller M, Khuseyinova N, Meisinger C, Martin S, Illig T, Koenig W, Thorand B.

Diabetologia. 2008 Feb;51(2):276-84. Epub 2007 Aug 22.


Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?

Khuseyinova N, Koenig W.

Mol Diagn Ther. 2007;11(4):203-17. Review.


Biomarkers of atherosclerotic plaque instability and rupture.

Koenig W, Khuseyinova N.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):15-26. Epub 2006 Nov 2. Review.


Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

Koenig W, Khuseyinova N, Baumert J, Thorand B, Loewel H, Chambless L, Meisinger C, Schneider A, Martin S, Kolb H, Herder C.

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2745-51. Epub 2006 Sep 28.


Biomarkers of outcome from cardiovascular disease.

Khuseyinova N, Koenig W.

Curr Opin Crit Care. 2006 Oct;12(5):412-9. Review.


Apolipoprotein A-I and risk for cardiovascular diseases.

Khuseyinova N, Koenig W.

Curr Atheroscler Rep. 2006 Sep;8(5):365-73. Review.


Supplemental Content

Loading ...
Support Center